Prior Authorization Required

Prior authorization is required when criteria for iontophoresis, surgical excision, or endoscopic thoracic sympathectomy (ETS) apply. Submit a request before scheduling services when any of the following procedures are planned: iontophoresis (CPT 97033), ETS (CPT 32664), surgical excision of axillary sweat glands (CPTs 11450, 11451), or related procedures listed below. Authorization decisions rely on documentation that meets the Required Clinical Documentation and Step Therapy criteria.

• Prior authorization required for iontophoresis (97033) when medically necessary criteria met
• Prior authorization required for ETS (32664) when medically necessary criteria met
• Prior authorization required for surgical excision (11450, 11451) when medically necessary criteria met

Step Therapy / Required Trial

Conservative management must be attempted and documented prior to authorization of more invasive therapies. Specifically, members must have failed a trial of conservative measures including adherent application of aluminum chloride hexahydrate (prescription Drysol) or have experienced severe topical-agent rash precluding continued use. For surgical excision or ETS, the member must have failed one of the following: iontophoresis or a trial of botulinum toxin (for predominantly axillary hyperhidrosis).

• Step therapy: Trial of prescription-strength topical aluminum chloride hexahydrate (Drysol) before iontophoresis
• For surgical excision: prior failure of iontophoresis or botulinum toxin trial
• For ETS: prior failure of iontophoresis or botulinum toxin where applicable

Required Clinical Documentation

Document the following in the prior authorization submission to support medical necessity: diagnosis of primary hyperhidrosis; description of the anatomic site(s) involved (eg, palms, axillae, soles); objective or descriptive evidence of functional impairment or medical complications (eg, skin maceration, recurrent skin infections, need to change clothing frequently, impact on work or social functioning); details of conservative treatments tried (agent, dose, duration, adherence) and outcomes or adverse reactions; contraindications to iontophoresis if applicable (pacemaker, arrhythmias, pregnancy, metal implants, epilepsy); and counseling on procedural risks for surgical options.

• Required: diagnosis of primary hyperhidrosis and affected sites
• Required: documentation of medical complications or significant functional/social impairment
• Required: documentation of conservative therapy trial(s) including duration and outcome (eg, Drysol use)
• Required: documentation of contraindications to iontophoresis when present (pacemaker, arrhythmias, pregnancy, metal implants, epilepsy)
• Required for surgical requests: documentation of counseling on procedural risks

Denial Triggers for Iontophoresis and Related Therapies

Common denial reasons include insufficient documentation of primary hyperhidrosis or affected sites, lack of documented medical complications or functional impact, absence of documented trial and failure of conservative therapies (or documented adverse reaction), and failure to document contraindications or reasons why less invasive treatments are not appropriate. Ensure the submission includes all required items above to avoid delays or denials.

• Denial trigger: Missing documentation of diagnosis or affected anatomic site(s)
• Denial trigger: No evidence of medical complications or significant functional impairment
• Denial trigger: No documented trial or failure of conservative therapy (eg, Drysol) or botulinum toxin/iontophoresis where required
• Denial trigger: Failure to document contraindications to iontophoresis when claimed